732245-99-7

Basic information

• Product Name: 5-ISOCYANATO-2-METHYL-PYRIDINE
• Synonyms: 5-ISOCYANATO-2-METHYL-PYRIDINE;Pyridine, 5-isocyanato-2-methyl- (9CI);5-ISOCYANATO-2-METHYL-PYRIDINE 95%;5-Isocyanato-2-methylpyridine ,95%;Pyridine, 5-isocyanato-2-Methyl-
• CAS NO: 732245-99-7
• Molecular Formula: C₇H₆N₂O
• Molecular Weight: 134.14
• Product Categories: PYRIDINE
• Mol File: 732245-99-7.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 203.9ºC at 760 mmHg
• Flash Point: 77.1ºC
• Appearance: /
• Density: 1.09g/cm3
• Vapor Pressure: 0.27mmHg at 25°C
• Refractive Index: 1.55
• CAS DataBase Reference: 5-ISOCYANATO-2-METHYL-PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-ISOCYANATO-2-METHYL-PYRIDINE(732245-99-7)
• EPA Substance Registry System: 5-ISOCYANATO-2-METHYL-PYRIDINE(732245-99-7)

Safety Data

• Hazardous Substances Data: 732245-99-7(Hazardous Substances Data)

Usage

Chemical Properties

Yellow liquid

InChI:InChI=1/C7H6N2O/c1-6-2-3-7(4-8-6)9-5-10/h2-4H,1H3

Upstream product

• 64038-04-6 6-methyl-nicotinoyl azide 
• 917-61-3 sodium isocyanate 
• 111770-91-3 (6-methylpyridin-3-yl)trifluoromethanesulfonate 
• 3222-47-7 6-methylnicotinic acid 
• 51598-76-6 6-methyl-nicotinoyl chloride 

Downstream Products

• 873697-65-5 4-{4-fluoro-3-[3-(6-methyl-pyridin-3-yl)-ureido]-benzyl}-piperazine-1-carboxylic acid tert-butyl ester 
• 873697-60-0 C₂₃H₃₀FN₅O₃ 
• 873697-71-3 methyl 4-[(2-fluoro-3-{[(6-methylpyridin-3-yl)carbamoyl]amino}phenyl)methyl]piperazine-1-carboxylate 
• 1384553-88-1 C₁₄H₁₂F₃N₃O₂ 

Relevant articles and documents

C-3 NOVEL TRITERPENONE WITH C-28 REVERSE AMIDE DERIVATIVES AS HIV INHIBITORS

Formula (I) The invention relates to C-3 novel triterpenone with C-28 reverse amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.

Oxindole derivatives

The invention describes compounds of the general formula I or the pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and X are herein described, a process for their manufacture, medicaments containing them as well as the use of these compounds as pharmaceutically active agents. The compounds show activity as antiproliferative agents and may be especially useful for the treatment of cancer.